Filing Details

Accession Number:
0001562180-19-000492
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-24 17:44:59
Reporting Period:
2019-01-23
Accepted Time:
2019-01-24 17:44:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235598 M James Frates C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-23 7,500 $8.92 11,735 No 4 M Direct
Common Stock Disposition 2019-01-23 7,500 $134.81 4,235 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-01-23 7,500 $0.00 7,500 $8.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,309 2024-05-21 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The shares subject to the option vested 33% on the first anniversary of the grant date and quarterly thereafter, such that 100% of the shares subject to the option were fully vested and exercisable on May 26, 2017.